Covington Capital has taken over management of two venture capital funds — New Generation Biotech Equity Fund and New General Biotech Balanced Fund – from Genesys Capital Partners. No financial terms were disclosed. In related news, NGBE has sold portions of its positions in Affinium Pharmaceuticals, Epocal and NeurAxon to “an institutional purchaser.”